ImmunityBio, Inc. SEC filings IBRX
ImmunityBio, Inc. has 554 filings in SEC EDGAR's recent list, going back to Apr 29, 2005. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 4, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 14, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Oct 14, 2026 | Oct 14, 2026 |
| 10-Q | Quarterly report | Aug 4, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2026 | Aug 4, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 30, 2026 | Jul 29, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2026 | Jun 9, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
May 18, 2026 | May 14, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| DEFA14A | Additional proxy material | Apr 30, 2026 | — |
| DEF 14A | Proxy statement | Apr 30, 2026 | Jun 9, 2026 |
| ARS | Annual report to shareholders | Apr 30, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Apr 9, 2026 | Apr 9, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 6, 2026 | Apr 6, 2026 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure, Other events
|
Mar 31, 2026 | Mar 30, 2026 |
| 10-K | Annual report | Feb 23, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 23, 2026 | Feb 23, 2026 |
| 8-K |
Current report
Other events
|
Feb 18, 2026 | Feb 18, 2026 |
| 8-K |
Current report
Material agreement
|
Jan 26, 2026 | Jan 23, 2026 |
| 8-K |
Current report
Results of operations
|
Jan 15, 2026 | Jan 15, 2026 |
| 8-K |
Current report
Other events
|
Jan 14, 2026 | Jan 14, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Dec 29, 2025 | Dec 23, 2025 |
| 424B5 | Prospectus supplement | Dec 29, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Dec 15, 2025 | Dec 10, 2025 |
| 8-K |
Current report
Other events
|
Dec 12, 2025 | Dec 12, 2025 |
| 10-Q | Quarterly report | Nov 5, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2025 | Nov 4, 2025 |
| DEF 14C | Information statement | Oct 20, 2025 | Oct 20, 2025 |
| PRE 14C | Filing | Oct 8, 2025 | Oct 8, 2025 |
| 8-K |
Current report
Other events
|
Aug 8, 2025 | Aug 8, 2025 |
| 10-Q | Quarterly report | Aug 5, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2025 | Aug 5, 2025 |
| 424B5 | Prospectus supplement | Jul 28, 2025 | — |
| 8-K |
Current report
Material agreement, Results of operations, Regulation FD disclosure, Other events
|
Jul 25, 2025 | Jul 24, 2025 |
| S-8 | Employee stock plan registration | Jun 23, 2025 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 20, 2025 | Jun 18, 2025 |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 12, 2025 | May 12, 2025 |
| 8-K |
Current report
Other events
|
May 5, 2025 | May 5, 2025 |
| DEFA14A | Additional proxy material | Apr 30, 2025 | — |
| ARS | Annual report to shareholders | Apr 30, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Apr 30, 2025 | Jun 18, 2025 |
| 8-K |
Current report
Results of operations
|
Apr 15, 2025 | Apr 15, 2025 |
| 424B5 | Prospectus supplement | Apr 8, 2025 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Apr 8, 2025 | Apr 7, 2025 |
| 8-K |
Current report
Auditor change
|
Mar 19, 2025 | Mar 13, 2025 |
| 10-K | Annual report | Mar 3, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 3, 2025 | Mar 3, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 13, 2025 | Feb 7, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 7, 2025 | Feb 7, 2025 |
| 424B5 | Prospectus supplement | Dec 12, 2024 | — |
| 8-K |
Current report
Material agreement, Other events
|
Dec 11, 2024 | Dec 10, 2024 |
| 8-K |
Current report
Other events
|
Dec 10, 2024 | Dec 10, 2024 |
| 424B5 | Prospectus supplement | Dec 10, 2024 | — |
| 8-K |
Current report
Other events
|
Nov 19, 2024 | Nov 19, 2024 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| 10-Q | Quarterly report | Aug 12, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Material agreement
|
Jul 18, 2024 | Jul 13, 2024 |
| S-8 | Employee stock plan registration | Jun 20, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2024 | Jun 11, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| EFFECT | Filing | May 2, 2024 | — |
| CORRESP | Letter to the SEC | Apr 30, 2024 | — |
| DEFA14A | Additional proxy material | Apr 29, 2024 | — |
| DEF 14A | Proxy statement | Apr 29, 2024 | Jun 11, 2024 |
| ARS | Annual report to shareholders | Apr 29, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 23, 2024 | Apr 22, 2024 |
| S-3ASR | Automatic shelf registration | Apr 17, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 3, 2024 | — |
| S-3 | Shelf registration | Mar 29, 2024 | — |
| CORRESP | Letter to the SEC | Mar 28, 2024 | — |
| 10-K | Annual report | Mar 19, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Officer or director change
|
Feb 26, 2024 | Feb 22, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Jan 2, 2024 | Dec 29, 2023 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| DEF 14C | Information statement | Sep 28, 2023 | Sep 28, 2023 |
| D | Filing | Sep 22, 2023 | — |
| PRE 14C | Filing | Sep 18, 2023 | Sep 15, 2023 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Sep 11, 2023 | Sep 11, 2023 |
| 8-K |
Current report
Other events
|
Sep 1, 2023 | Aug 31, 2023 |
| 8-K |
Current report
Other events
|
Aug 15, 2023 | Aug 14, 2023 |
| 10-Q | Quarterly report | Aug 8, 2023 | Jun 30, 2023 |
| 424B5 | Prospectus supplement | Jul 25, 2023 | — |
| 424B5 | Prospectus supplement | Jul 24, 2023 | — |
| 8-K |
Current report
Material agreement
|
Jul 21, 2023 | Jul 20, 2023 |
| 8-K |
Current report
Other events
|
Jul 20, 2023 | Jul 20, 2023 |
| 8-K |
Current report
Material agreement, New debt, Shareholder vote results
|
Jun 14, 2023 | Jun 13, 2023 |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Other events
|
May 11, 2023 | May 9, 2023 |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| DEF 14A | Proxy statement | Apr 28, 2023 | — |
| ARS | Annual report to shareholders | Apr 28, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Material agreement, New debt
|
Mar 31, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Other events
|
Mar 20, 2023 | Mar 20, 2023 |
| 10-K | Annual report | Mar 1, 2023 | Dec 31, 2022 |
| 424B5 | Prospectus supplement | Feb 16, 2023 | — |
| 8-K |
Current report
Material agreement
|
Feb 15, 2023 | Feb 15, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 14, 2023 | Feb 14, 2023 |
| 8-K |
Current report
Other events
|
Feb 13, 2023 | Feb 7, 2023 |
| EFFECT | Filing | Feb 9, 2023 | — |
| CORRESP | Letter to the SEC | Feb 8, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 8, 2023 | — |
| S-3 | Shelf registration | Feb 7, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 11, 2023 | — |
| CORRESP | Letter to the SEC | Jan 5, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 20, 2022 | — |
| 8-K |
Current report
Material agreement, Results of operations, New debt, Regulation FD disclosure, Other events
|
Dec 12, 2022 | Dec 12, 2022 |
| 424B5 | Prospectus supplement | Dec 12, 2022 | — |
| S-3MEF | Filing | Dec 12, 2022 | — |
| 424B5 | Prospectus supplement | Dec 12, 2022 | — |
| 8-K |
Current report
Other events
|
Dec 5, 2022 | Dec 2, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 15, 2022 | Nov 15, 2022 |
| 10-Q | Quarterly report | Nov 9, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Material agreement, New debt
|
Sep 2, 2022 | Aug 31, 2022 |
| 10-Q | Quarterly report | Aug 8, 2022 | Jun 30, 2022 |
| D | Filing | Jul 22, 2022 | — |
| S-8 | Employee stock plan registration | Jun 14, 2022 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2022 | Jun 14, 2022 |
| 424B5 | Prospectus supplement | May 26, 2022 | — |
| EFFECT | Filing | May 18, 2022 | — |
| POS EX | Filing | May 18, 2022 | — |
| AW | Filing | May 18, 2022 | — |
| S-3/A | Filing | May 16, 2022 | — |
| 10-Q | Quarterly report | May 10, 2022 | Mar 31, 2022 |
| DEFA14A | Additional proxy material | Apr 29, 2022 | — |
| DEF 14A | Proxy statement | Apr 29, 2022 | Jun 14, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 25, 2022 | Mar 23, 2022 |
| POS AM | Filing | Mar 7, 2022 | — |
| 10-K | Annual report | Mar 1, 2022 | Dec 31, 2021 |
| POSASR | Filing | Mar 1, 2022 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure
|
Feb 15, 2022 | Feb 14, 2022 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jan 12, 2022 | Jan 7, 2022 |
| DEF 14C | Information statement | Jan 11, 2022 | Jan 11, 2022 |
| PRE 14C | Filing | Dec 30, 2021 | Dec 29, 2021 |
| 8-K |
Current report
Material agreement, New debt, Bylaw or fiscal year change, Regulation FD disclosure
|
Dec 20, 2021 | Dec 17, 2021 |
| 10-Q | Quarterly report | Nov 12, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Material agreement
|
Sep 27, 2021 | Sep 27, 2021 |
| 8-K |
Current report
Results of operations, Other events
|
Sep 13, 2021 | Sep 13, 2021 |
| 8-K |
Current report
Officer or director change
|
Aug 13, 2021 | Aug 9, 2021 |
| 10-Q | Quarterly report | Aug 12, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jun 15, 2021 | Jun 15, 2021 |
| 8-K |
Current report
Results of operations, Shareholder vote results
|
Jun 11, 2021 | Jun 11, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 4, 2021 | Jun 4, 2021 |
| 8-K |
Current report
Material agreement
|
May 28, 2021 | May 28, 2021 |
| EFFECT | Filing | May 26, 2021 | — |
| S-8 POS | Filing | May 21, 2021 | — |
| POS AM | Filing | May 21, 2021 | — |
| 10-Q | Quarterly report | May 14, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Material agreement, Results of operations
|
May 3, 2021 | Apr 30, 2021 |
| 424B5 | Prospectus supplement | May 3, 2021 | — |
| S-3ASR | Automatic shelf registration | Apr 30, 2021 | — |
| DEF 14A | Proxy statement | Apr 29, 2021 | Jun 10, 2021 |
| 8-K/A |
Amended current report
Other events
|
Apr 22, 2021 | Mar 5, 2021 |
| 8-K |
Current report
Officer or director change
|
Apr 1, 2021 | Mar 29, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 17, 2021 | Mar 17, 2021 |
| 8-K |
Current report
Acquisition or sale of assets, New debt, Officer or director change, Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure, Other events
|
Mar 10, 2021 | Mar 5, 2021 |
| 425 | Filing | Mar 8, 2021 | — |
| 10-K | Annual report | Mar 4, 2021 | Dec 31, 2020 |
| 425 | Filing | Mar 2, 2021 | — |
| 425 | Filing | Feb 25, 2021 | — |
| 8-K |
Current report
Other events
|
Feb 25, 2021 | Feb 25, 2021 |
| 425 | Filing | Feb 25, 2021 | — |
| 425 | Filing | Feb 24, 2021 | — |
| 8-K |
Current report
Other events
|
Feb 24, 2021 | Feb 24, 2021 |
| 8-K |
Current report
Officer or director change
|
Feb 10, 2021 | Feb 5, 2021 |
| DEFM14A | Filing | Feb 2, 2021 | — |
| 424B3 | Prospectus | Feb 2, 2021 | — |
| EFFECT | Filing | Feb 1, 2021 | — |
| S-4/A | Filing | Jan 29, 2021 | — |
| S-4 | Registration for a merger or exchange | Jan 19, 2021 | — |
| 425 | Filing | Jan 13, 2021 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2021 | Jan 13, 2021 |
| 425 | Filing | Dec 22, 2020 | — |
| 425 | Filing | Dec 22, 2020 | — |
| 8-K |
Current report
Material agreement
|
Dec 22, 2020 | Dec 21, 2020 |
| 425 | Filing | Dec 21, 2020 | — |
| 425 | Filing | Dec 21, 2020 | — |
| 425 | Filing | Dec 21, 2020 | — |
| 8-K |
Current report
Other events
|
Dec 21, 2020 | Dec 21, 2020 |
| 10-Q | Quarterly report | Nov 9, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Officer or director change
|
Oct 26, 2020 | Oct 26, 2020 |
| 8-K |
Current report
Material agreement
|
Aug 24, 2020 | Aug 21, 2020 |
| S-8 | Employee stock plan registration | Aug 10, 2020 | — |
| 10-Q | Quarterly report | Aug 7, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Other events
|
Jun 25, 2020 | Jun 24, 2020 |
| 424B5 | Prospectus supplement | Jun 25, 2020 | — |
| 8-K |
Current report
Other events
|
Jun 24, 2020 | Jun 24, 2020 |
| 424B5 | Prospectus supplement | Jun 24, 2020 | — |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change
|
Jun 19, 2020 | Jun 16, 2020 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 12, 2020 | Jun 10, 2020 |
| 8-K |
Current report
Material agreement
|
May 27, 2020 | May 22, 2020 |
| 10-Q | Quarterly report | May 11, 2020 | Mar 31, 2020 |
| DEF 14A | Proxy statement | Apr 24, 2020 | Jun 10, 2020 |
| 10-K | Annual report | Mar 25, 2020 | Dec 31, 2019 |
| 10-Q | Quarterly report | Nov 5, 2019 | Sep 30, 2019 |
| EFFECT | Filing | Sep 3, 2019 | — |
| CORRESP | Letter to the SEC | Aug 29, 2019 | — |
| UPLOAD | Letter from the SEC | Aug 28, 2019 | — |
| S-3 | Shelf registration | Aug 23, 2019 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Aug 7, 2019 | Aug 2, 2019 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- IBRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1326110
- Former names
- NantKwest, Inc. (until Mar 8, 2021); Conkwest, Inc. (until Jul 13, 2015); ZelleRx Corp (until Oct 9, 2009)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.